Skip to main content

Valve-in-valve Procedures

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pi-Cardia
Pi-CardiaIsrael - Rehovot
1 program
ShortcutN/A2 trials
Active Trials
NCT07631988Not Yet Recruiting150Est. Sep 2027
NCT06211296Completed8Est. May 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
Pi-CardiaShortcut
Pi-CardiaShortcut

Clinical Trials (2)

Total enrollment: 158 patients across 2 trials

The ShortCut Post-Market Study

Start: Jun 2026Est. completion: Sep 2027150 patients
N/ANot Yet Recruiting

The ShortCut™ Continued Access Study Protocol

Start: Jul 2024Est. completion: May 20258 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.